Page results
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
This page provides information about the thermoregulatory sweat test (TST).
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
This page provides information about different medicines that might help to relieve neuropathic pain.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Information on parvovirus for patients with haemolytic anaemias.
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
File results
-
FOI/2024/0697 - Autism spectrum disorder (ASD)/ attention deficit hyperactivity disorder (ADHD) and mental health services
-
FOI/2024/0696 - Various IT systems used at Trust
-
FOI/2024/0695 - Air filtration used/ air exchange rate across Trust
-
FOI/2024/0693 - Patients overhead or ceiling track hoists portable/ mobile hoists installed
-
FOI/2024/0692 - Integrated Care Board (ICB) expenditure sign-off process 2023/24
-
FOI/2024/0691 - Information distributed to pregnant/ post-partum women for infant feeding
-
FOI/2024/0690 - Mechanical transport ventilation/ ventway sparrow transport ventilator
-
FOI/2024/0687 - Newly diagnosed patients with AML starting first line treatment - February-July 2024
-
FOI/2024/0685 - Lunch/ dinner menus for patients
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma